July 14, 2024
Acellular Dermal Matrices Market

Acellular Dermal Matrices Market Estimated To Witness High Growth Owing To Rising Skin Graft Procedures

The Acellular Dermal Matrices Market is estimated to be valued at US$ 8.8 Bn in 2022 and is expected to exhibit a CAGR of 12.1% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Acellular dermal matrices (ADMs) are generally used for reconstructive and breast reconstructive surgeries. They help to replace damaged or missing collagen and tissue and provide structure and reinforcement for healing. ADMs contain minimal cellular components and tissue proteins but maintain the three-dimensional scaffold architecture that encourages tissue regeneration. The extracellular matrix derived from human or animal sources is combined with the patient’s own tissue to form new collagen and promote wound healing.

Market Dynamics:

The global acellular dermal matrices market is witnessing significant growth, owing to the rising number of skin graft procedures including burn reconstruction and breast reconstruction. Additionally, the increasing prevalence of wounds such as pressure ulcers, diabetic foot ulcers, and trauma injuries is augmenting the demand for acellular dermal matrices. For instance, according to the World Health Organization (WHO), there were approximately 1.35 million deaths globally due to road traffic accidents in 2020. Furthermore, key players operating in the market are focusing on obtaining approvals for new acellular dermal matrices products and expanding their geographic footprint, which is positively impacting the market growth. For example, in January 2022, Anthropic received FDA approval for its Grafix acellular dermal matrix used for the treatment of acute and chronic wounds.

Segment Analysis

The acellular dermal matrices market is dominated by the alloderm segment owing to its widespread adoption in breast reconstruction procedures. Alloderm is a human acellular dermal matrix that finds major use for chest wall reconstruction and breast reconstruction after mastectomy. Its ability to revascularize and remodel into host tissue makes it a preferred choice for such reconstructions.

PEST Analysis

Political: There are no major political factors influencing the Acellular Dermal Matrices Market currently. However, future changes in healthcare policies could impact market dynamics.
Economic: The market is driven by rising healthcare spending globally and growing demand for reconstructive surgeries among aging populations.
Social: Increased awareness about cosmetic procedures and breast reconstruction options after mastectomy is propelling the demand for acellular dermal matrices.
Technological: Development of advanced acellular matrices with improved handling properties and enhanced tissue integration is supporting the market growth.

Key Takeaways

The global acellular dermal matrices market is expected to witness high growth, exhibiting a CAGR of 12.1% over the forecast period, due to increasing demand for breast reconstruction procedures worldwide.
The US dominates the global market owing to the high prevalence of breast cancer and established healthcare infrastructure in the country. Moreover, favorable reimbursement policies further support market growth in the region.

Key players operating in the acellular dermal matrices market are Integra LifeSciences Corporation, AbbVie Inc., Johnson & Johnson, HansBioMed, Becton, Dickinson and Company, Cook Group, Smith & Nephew Plc., Reprise Biomedical, Organogenesis Holdings Inc., Tissue Regenix, LifeNet Health, Zimmer Biomet Holdings, Inc., Stryker Corporation, MiMedx Group, PolyNovo Limited, Fidia Pharma USA Inc., Baxter International Inc., In2Bones Global, BioHorizons, Inc., Harbor MedTech, Inc., MLM Biologics Inc., Geistlich Pharma AG, Olaregen Theriotix, Inc., EnColl Corporation, Kerecis limited, DSM, ACell Inc., 3M, Cell Constructs I, LLC, CG bio Inc., and Marine Polymer Technologies, Inc.

Regional analysis reveals that North America is the fastest growing as well as the dominating regional market. This can be attributed to the high incidence of breast cancer, growing cosmetic procedures, and favorable reimbursement policies in the region, especially in the US.

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it